matrix metalloproteinase-9 (MMP-9), S100 calcium-binding protein A8 (S100A8), S100 calcium-binding protein A9 (S100A9), Bv8, and high mobility group box 1 (HMGB1) (169, 170)
Key Mechanisms of Action: Stimulates Lipolysis (Fat Breakdown) AOD-9604 activates beta-3 adrenergic receptors in adipose (fat) tissue, triggering the release of stored fatty acids for energy use
Seok JW
Their structural resemblance to biological membranescomprising phospholipids and cholesterol, confers enhanced biocompatibility and facilitates efficient transfollicular drug delivery [213, 214]
Role of Oxidative Stress in the Pathogenesis of Non-alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
AOD vs GLP-1 GLP-1 agonists (semaglutide, tirzepatide) are our primary medical weight-loss lane with the strongest evidence